MERCY WAINAINA: Open Payments
NPI 1427605609 · LYNNWOOD, WA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,062 in 93 payments from 15 companies in 2025. Trend: 2023 $1,726 · 2024 $2,158 · 2025 $2,062
Food & beverage: $1,950Education: $111
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 21 | $412 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 15 | $334 |
| Teva Pharmaceuticals USA, Inc. | 6 | $249 |
| Supernus Pharmaceuticals, Inc. | 14 | $200 |
| Axsome Therapeutics, Inc. | 9 | $161 |
| Neurocrine BioSciences, Inc. | 2 | $160 |
| Alkermes, Inc. | 7 | $140 |
| Otsuka America Pharmaceutical, Inc. | 4 | $105 |
| Janssen Pharmaceuticals, Inc | 4 | $74 |
| Collegium Pharmaceutical, Inc. | 3 | $65 |
Products named: VRAYLAR, CAPLYTA, Qelbree, Auvelity, INGREZZA, ARISTADA, REXULTI, AUSTEDO XR.
Industry payments across WA — which companies pay providers there.
